Texas Biotechnology Corp Articles

Encouraging findings for sitaxsentan from STRIDE trial

26 May 2003

Texas Biotech announces financial loss

4 March 2002

Texas Biotech adopts shareholder rights plan

14 January 2002

Texas' German subsidiary looking to get funding of 30 million DM

3 August 2000

Texas set to gain from ICOS joint venture

8 June 2000

Texas Biotechnology Corp issuing 5 million shares

11 April 2000

Argatroban In Acute Myocardial Infarction

8 April 1998

New Studies At European Cardiology Meeting

15 September 1997

Synthelabo Signs Deal With Texas Biotech

24 October 1994

TEXAS BIOTECH IN ALLIANCE

23 August 1993

Showing 1-10 of 10 articles

Go to beginningPrevious
  • 1
NextGo to end